I absolutely acknowledge I don't know what the 'with' and 'for' percentages of COVID bed occupancy are for UK.
Why does this not get more coverage? Might this reduce the 'fear' factor, and would that be a good thing or not?
On 'Long COVID':
Post-acute COVID-19 syndrome, better known as long COVID or long-haul COVID is really hard to define. On 6 Oct, the
WHO released a consensus case definition for long COVID that is rather vague. It defines the syndrome thus:
- Occurs in those with a history or probable history of SARS-CoV-2 infection;
- Involves symptoms that occur or persist 3 months from infection;
- Has symptoms that last at least 2 months; and
- Cannot be explained by an alternative diagnosis.
What symptoms might count? The list includes brain fog, abdominal pain, palpitations, anxiety, and new allergies, among others.
Medscape article
Concludes (precised):
Frustrated with how we're handling long COVID:
- case definition is bad
- zero diagnostic tests
- some argue it isn't even a real problem
- long COVID definitely exists;
- we don't know how common it is
- need to recognize that vague symptoms lead to vague diagnoses
- risk labeling a bunch of people with "long COVID" when that's not what they have at all
- does a disservice to all because it makes it that much harder to make progress on this disease...whatever it is.
Author: F. Perry Wilson, MD, MSCE, Associate professor of medicine and director of Yale's Clinical and Translational Research Accelerator.